Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis (MS) are two of the most debilitating neurologic diseases of adults, of unknown cause and without adequate treatment. Evidence exists that both may be due in part to a persistent virus infection an immune abnormality, or both. The purpose of this Center is to bring together basic scientists and academic neurologists with complementary skills to attack the fundamental problems of ALS and MS. Such a program must function at multiple levels. Basic studies employing tissue cultures or organotypic cultures may provide fundamental biologic clues. Animal model systems which faithfully reproduce elements of human ALS or MS and the complexities of mammalian disease will be of great usefulness. Finally, human studies which can build on the findings from the animal investigations or provide insights that can be pursued more fully in suitable animal models will be undertaken. The ultimate goal is to design and initiate human clinical trials based on firm evidence of disease mechanisms in ALS or MS. In-vitro and in-vivo models of CNS virus persistence and demyelination will be studied. Mechanisms of demyelination will be investigated in both the central and peripheral nervous system. Human studies will explore the abnormalities of the immune response in MS and search for the target within the CNS. Molecular biological, virological cellular and humeral immunological, neuropathological and clinical approaches will be employed. A central focus of this Center will be an ALS/MS Clinic where well characterized patients and appropriate controls can be studied. Such patients will contribute materials for the projects described and will participate in logical clinical trials of experimental therapy. The instruction of health professionals interested in this condition will be fostered. This Center Grant will provide the foundation for a program of breadth confronting the clinical problems of ALS and MS from diagnosis to rehabilitation. It will concurrently provide the scientific depth to hopefully unravel the mysteries of these diseases and lead to rational treatment or prevention.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
5P50NS020022-02
Application #
3107762
Study Section
Neurological Disorders Program Project Review A Committee (NSPA)
Project Start
1983-12-01
Project End
1986-11-30
Budget Start
1984-12-01
Budget End
1985-11-30
Support Year
2
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Maryland Baltimore
Department
Type
Schools of Medicine
DUNS #
003255213
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Dashiell, S M; Rus, H; Koski, C L (2000) Terminal complement complexes concomitantly stimulate proliferation and rescue of Schwann cells from apoptosis. Glia 30:187-98
Dhib-Jalbut, S; Xia, J; Rangaviggula, H et al. (1999) Failure of measles virus to activate nuclear factor-kappa B in neuronal cells: implications on the immune response to viral infections in the central nervous system. J Immunol 162:4024-9
Dashiell, S M; Koski, C L (1999) Sublytic terminal complement complexes decrease P0 Gene expression in Schwann cells. J Neurochem 73:2321-30
Cheng, G; Nazar, A S; Shin, H S et al. (1998) IP-10 gene transcription by virus in astrocytes requires cooperation of ISRE with adjacent kappaB site but not IRF-1 or viral transcription. J Interferon Cytokine Res 18:987-97
Jiang, H; Williams, G J; Dhib-Jalbut, S (1997) The effect of interferon beta-1b on cytokine-induced adhesion molecule expression. Neurochem Int 30:449-53
Dashiell, S M; Vanguri, P; Koski, C L (1997) Dibutyryl cyclic AMP and inflammatory cytokines mediate C3 expression in Schwann cells. Glia 20:308-21
Klyushnenkova, E N; Vanguri, P (1997) Ia expression and antigen presentation by glia: strain and cell type-specific differences among rat astrocytes and microglia. J Neuroimmunol 79:190-201
Vanguri, P; Cho, S Y; Chi, C M (1996) Role of muIP-10 in interferon-gamma induction of Ia in rat astrocytes. Mol Immunol 33:1079-87
Wojcik, W J; Swoveland, P; Zhang, X et al. (1996) Chronic intrathecal infusion of phosphorothioate or phosphodiester antisense oligonucleotides against cytokine responsive gene-2/IP-10 in experimental allergic encephalomyelitis of lewis rat. J Pharmacol Exp Ther 278:404-10
Dhib-Jalbut, S; Gogate, N; Jiang, H et al. (1996) Human microglia activate lymphoproliferative responses to recall viral antigens. J Neuroimmunol 65:67-73

Showing the most recent 10 out of 21 publications